# Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors

> **NCT00746603** · NA · TERMINATED · sponsor: **Columbia University** · enrollment: 3 (actual)

## Conditions studied

- Carotid Artery Disease

## Interventions

- **DRUG:** Simvastatin

## Key facts

- **NCT ID:** NCT00746603
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2008-01
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Poor enrollment
- **Last updated:** 2021-03-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00746603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00746603, "Feasibility Study of Simvastatin in Hodgkin's Lymphoma Survivors". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00746603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*